Simone Parisi
ScholarGPS® ID: 67032798677682
Affiliation History
Field
Medicine
Discipline
Rheumatology
Top Specialties
Arthritis | Systemic Scleroderma | Rheumatoid Arthritis | Interstitial Lung Disease | Psoriasis | Psoriatic Arthritis | Respiratory Disease | Thorax | Adalimumab
Metrics Summary
Publication Count
84
Predicted Citations
757
Predicted h-index
15
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Subcutaneous infliximab CT-P13 without intravenous induction in psoriatic arthritis: A case report and pharmacokinetic considerations (journal article) Int. Journal of Clinical Pharmacology and Therapeutics, volume 62, issue 03, pages 122-125 (2024). |
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study (journal article) Journal of Clinical Medicine, volume 13, issue 2, pages 401- (2024). |
EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy (2023) |
EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy (2023) |
EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy (2023) |
EULAR 2023 European Congress of Rheumatology, 31 May - 3 June. Milan, Italy (2023) |
Management of Patients Affected by Giant Cell Arteritis during the COVID-19 Pandemic: Telemedicine Protocol TELEMACOV (journal article) Journal of Personalized Medicine, volume 13, issue 4, pages 620- (2023). |
New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria®) Vaccine Administration (journal article) Vaccines, volume 11, issue 2, pages 434- (2023). |
How immunosuppressive therapy impaires on COVID-19 mRNA-vaccine response in rheumatic diseases (journal article) Minerva Medica, volume 113, issue 5 (2022). |
Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life (book chapter) In Biosimilars IntechOpen (2022) |
AB0341 EFFICACY AND DRUG SURVIVAL AFTER MULTIPLE-SWITCHING FROM ADALIMUMAB ORIGINATOR TO THE BIOSIMILARS ABP501 AND SB5: A REAL-LIFE STUDY (journal article) Annals of the Rheumatic Diseases, volume 81, issue Suppl 1, pages 1295-1296 (2022). |
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis (journal article) Journal of Personalized Medicine, volume 12, issue 3, pages 335- (2022). |
Clinical and Experimental Rheumatology (2022). |
Biology, volume 10, issue 11, pages 1071- (2021). |
Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis (journal article) RMD Open, volume 7, issue 3, pages e001755- (2021). |
Reumatismo, volume 73, issue 2, pages 89-105 (2021). |
Clinical and Experimental Rheumatology (2021). |
POS0090 RISK OF QT INTERVAL PROLONGATION ASSOCIATED WITH CHRONIC USE OF HYDROXYCHLOROQUINE IN RHEUMATIC PATIENTS AND THE EFFECT OF COTREATMENTS (journal article) Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 254-254 (2021). |
AB0588 “ESORT” ITALIAN SOCIETY OF RHEUMATOLOGY (SIR) REGISTER ON OSTEOARTHRITIS (OA): PRELIMINARY DATA (journal article) Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 1331.1-1331 (2021). |
POS1243 TELEMEDICINE AND MANAGEMENT OF THE PATIENT AFFECTED BY GIANT CELL ARTERITIS DURING THE COVID-19 PANDEMIC - TELEMACOV (journal article) Annals of the Rheumatic Diseases, volume 80, issue Suppl 1, pages 904.2-905 (2021). |